Alper Biotechis a biotechnology company specializing in the identification, development and commercialization of novel highly-specific monoclonal antibody-based diagnostic assays in cancer.
Alper's monoclonal antibodies uniquely recognize proteins that are modified and differentially expressed in cancer cells. This novel and proprietary approach to cancer diagnostics will be applied to a variety of search and clinical testing applications.
Alper's pipeline of cancer diagnostic kits will cover many tumor types starting with breast cancer and expanding into other tumors of major concern to Oncologists. Alper's monoclonal antibodies are selected to help address high unmet medical needs in managing cancer diagnosis and therapy today.
Products
Alper Biotech's products provide unique proprietary highly-specific monoclonal antibodies with which to recognize the desired target protein(s). The products listed below are for research use only.
| Antibody | Applications | Catalogue No.
| Datasheet |
Alper-PCBP1 IHC Kit
IgG1 MoAb | 
immunohistochemistry | AB1 | 
|
Alper-Her2 IHC Kit
IgG1 MoAb | 
immunohistochemistry | AB11 |
|
